Literature DB >> 1568284

Resistance to cytostatic drugs at the cellular level.

C P Vendrik1, J J Bergers, W H De Jong, P A Steerenberg.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1568284     DOI： 10.1007/bf00684841

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  240 in total

1.  Dominance of colchicine resistance in hybrid CHO cells.

Authors:  V Ling; R M Baker
Journal:  Somatic Cell Genet       Date:  1978-03

2.  Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine.

Authors:  M Inaba; R Fujikura; S Tsukagoshi; Y Sakurai
Journal:  Biochem Pharmacol       Date:  1981-08-01       Impact factor: 5.858

3.  Membrane alterations associated with progressive adriamycin resistance.

Authors:  C Wheeler; R Rader; D Kessel
Journal:  Biochem Pharmacol       Date:  1982-08-15       Impact factor: 5.858

4.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

Authors:  A R Safa; C J Glover; J L Sewell; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

5.  DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.

Authors:  P G Debenham; N Kartner; L Siminovitch; J R Riordan; V Ling
Journal:  Mol Cell Biol       Date:  1982-08       Impact factor: 4.272

6.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

7.  Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells.

Authors:  J Jolivet; R L Schilsky; B D Bailey; J C Drake; B A Chabner
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo.

Authors:  F M Sirotnak; L J Goutas; L S Mines
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

9.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

Authors:  D R Bell; J H Gerlach; N Kartner; R N Buick; V Ling
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

10.  Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture.

Authors:  E Frei; A Rosowsky; J E Wright; C A Cucchi; J A Lippke; T J Ervin; J Jolivet; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205
View more
  9 in total

1.  Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.

Authors:  M A Izquierdo; G L Scheffer; M J Flens; G Giaccone; H J Broxterman; C J Meijer; P van der Valk; R J Scheper
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 2.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  New methods to assess 6-thiopurine toxicity and expanding its therapeutic application to pancreatic cancer via small molecule potentiators.

Authors:  Chamitha Weeramange; Ashabha Lansakara; Johnathan Dallman; Thi Nguyen; Wasundara Hulangamuwa; Ryan J Rafferty
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

Review 4.  Multidrug resistance in cancer chemotherapy.

Authors:  N H Patel; M L Rothenberg
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

5.  The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug-resistant cells.

Authors:  L Warren; A Malarska; J C Jardillier
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

6.  Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.

Authors:  C Etievant; J M Barret; A Kruczynski; D Perrin; B T Hill
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

7.  Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.

Authors:  J Zacherl; G Hamilton; T Thalhammer; M Riegler; E P Cosentini; A Ellinger; G Bischof; M Schweitzer; B Teleky; T Koperna
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 8.  Role of protein kinases in antitumor drug resistance.

Authors:  H Grunicke; J Hofmann; I Utz; F Uberall
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

Review 9.  The phospholipid membrane compositions of bacterial cells, cancer cell lines and biological samples from cancer patients.

Authors:  Kira L F Hilton; Chandni Manwani; Jessica E Boles; Lisa J White; Sena Ozturk; Michelle D Garrett; Jennifer R Hiscock
Journal:  Chem Sci       Date:  2021-09-28       Impact factor: 9.825
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.